Healthcare Stock Comparison

Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
PFEPfizer
$42.81
0.02 (0.05%)
$44.36
(3.62% Upside)
$239.64B
18.30
22.63%
2Buy
9Hold
1Sell
Hold
NVSNovartis
$92.39
0.2 (0.22%)
$92.35
(-0.04% Downside)
$206.65B
22.90
11.75%
0Buy
0Hold
1Sell
Moderate Sell
MRKMerck & Company
$76.87
-0.06 (-0.08%)
$93.57
(21.72% Upside)
$194.64B
28.40
5.50%
5Buy
3Hold
0Sell
Moderate Buy
JNJJohnson & Johnson
$172.20
0.02 (0.01%)
$190.86
(10.84% Upside)
$453.31B
25.90
21.25%
7Buy
1Hold
0Sell
Strong Buy
RHHBYRoche Holding
$48.26
0.5 (1.05%)
$329.81B
20.40
8.45%
2Buy
0Hold
0Sell
Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Healthcare Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
PFEPfizer Inc
premium
premium
Hold
premium
premium
Reiterated
MRKMerck & Company
premium
premium
Buy
premium
premium
Reiterated
NVSNovartis AG
premium
premium
Sell
premium
premium
Reiterated
JNJJohnson & Johnson
premium
premium
Buy
premium
premium
Reiterated
RHHBYRoche Holding AG
premium
premium
Buy
premium
premium
Initiated
MRKMerck & Company
premium
premium
Buy
premium
premium
Assigned
PFEPfizer Inc
premium
premium
Hold
premium
premium
Reiterated
PFEPfizer Inc
premium
premium
Hold
premium
premium
Reiterated
PFEPfizer Inc
premium
premium
Hold
premium
premium
Reiterated
PFEPfizer Inc
premium
premium
Hold
premium
premium
Assigned

Most Recent Earnings of Healthcare Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
PFEPfizer
Jul 28, 2021
2021 (Q2)
0.97 / 0.98
0.61
60.66% (+0.37)
NVSNovartis
Jul 21, 2021
2021 (Q2)
1.55 / -
0.821
MRKMerck & Company
Jul 29, 2021
2021 (Q2)
1.31 / -
1.184
JNJJohnson & Johnson
Jul 21, 2021
2021 (Q2)
2.29 / 2.35
1.36
72.79% (+0.99)
RHHBYRoche Holding
Jul 22, 2021
2021 (Q2)
1.37 / -
1.223

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?
These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:
Johnson & Johnson - Strong Buy, based on 8 analyst ratings, 7 Buy, 1 Hold, and 0 Sell.
    Are Healthcare stocks overpriced?
    Pfizer's stock price is currently $42.81, and its average 12-month price target is $44.36.
      Novartis's stock price is currently $92.39, and its average 12-month price target is $92.35.
        Merck & Company's stock price is currently $76.87, and its average 12-month price target is $93.57.
          Johnson & Johnson's stock price is currently $172.20, and its average 12-month price target is $190.86.
            Roche Holding's stock price is currently $48.26, and its average 12-month price target is N/A.
              Which Healthcare stocks pay dividends?
              Pfizer does not currently pay dividends.
                Novartis does not currently pay dividends.
                  Merck & Company currently pays a dividend of $0.65 which represents an annual dividend yield of 3.30%. Merck & Company's next Ex-dividend date is September 14, 2021 and its next payout date is October 7, 2021.
                    Johnson & Johnson currently pays a dividend of $1.06 which represents an annual dividend yield of 2.41%. Johnson & Johnson's next Ex-dividend date is August 23, 2021 and its next payout date is September 7, 2021.
                      Roche Holding does not currently pay dividends.